Notice: This company has been marked as potentially delisted and may not be actively trading. ARCA biopharma (ABIO) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisDividendEarningsHeadlinesInsider TradesOwnershipShort InterestTrends ARCA biopharma (NASDAQ:ABIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage30.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.67 MNumber OfInsiders Selling(Last 12 Months)0 Get ABIO Insider Trade Alerts Want to know when executives and insiders are buying or selling ARCA biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ABIO Insider Buying and Selling by Quarter Ad Genesis Gold GroupBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now ARCA biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/16/2024Henderson Group Plc JanusMajor ShareholderBuy40$421.92$16,876.80 7/24/2024Henderson Group Plc JanusMajor ShareholderBuy1,318$460.80$607,334.40 7/10/2024Henderson Group Plc JanusMajor ShareholderBuy385$498.24$191,822.40 7/8/2024Henderson Group Plc JanusMajor ShareholderBuy329$498.24$163,920.96 7/5/2024Henderson Group Plc JanusMajor ShareholderBuy196$493.92$96,808.32 7/3/2024Henderson Group Plc JanusMajor ShareholderBuy1,153$511.20$589,413.60 (Data available from 1/1/2013 forward) ABIO Insider Trading Activity - Frequently Asked Questions Who is on ARCA biopharma's Insider Roster? The list of insiders at ARCA biopharma includes Fund Lp Funicular, and Henderson Group Plc Janus. Learn more on insiders at ABIO. What percentage of ARCA biopharma stock is owned by insiders? 30.90% of ARCA biopharma stock is owned by insiders. Learn more on ABIO's insider holdings. Which ARCA biopharma insiders have been buying company stock? The following insider purchased ABIO shares in the last 24 months: Henderson Group Plc Janus ($1,666,176.48). How much insider buying is happening at ARCA biopharma? Insiders have purchased a total of 3,421 ABIO shares in the last 24 months for a total of $1,666,176.48 bought. ARCA biopharma Key ExecutivesMr. Thomas A. Keuer (Age 65)President, COO & Principal Executive Officer Compensation: $400.8kMr. C. Jeffrey Dekker CPA (Age 59)CFO, Treasurer & Company Secretary Compensation: $323.07k More Insider Trading Tools from MarketBeat Related Companies ImmuCell Insider Trades Acumen Pharmaceuticals Insider Trades Sagimet Biosciences Insider Trades Black Diamond Therapeutics Insider Trades Candel Therapeutics Insider Trades Skye Bioscience Insider Trades Cidara Therapeutics Insider Trades Cardiff Oncology Insider Trades Coherus BioSciences Insider Trades Pyxis Oncology Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ABIO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARCA biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARCA biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABIO Stock Alerts